Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells - Concepedia

Concepedia

Publication | Closed Access

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells

46

Citations

47

References

2007

Year

Michele L. Scotti, John F. Langenheim, Seth Tomblyn, Alison E. B. Springs, Wen Y. Chen

Breast Cancer Research and Treatment

Prolactin Receptor AntagonistBreast OncologyMedicineHormonal ReceptorAdditive EffectsBreast CancerAnti-cancer AgentPharmacologyCell BiologyEndocrine-related Cancer

References

	Year	Citations

Page 1